on NOVACYT (EPA:ALNOV)
Novacyt Announces Financial Results and Annual General Meeting
Novacyt S.A., a notable international molecular diagnostics company, will release its audited financial results for the year ending 31 December 2023 on Thursday, 30 May 2024. The announcement will be supported by an investor webinar led by CEO Lyn Rees and CFO Steve Gibson at 11:00 am BST on the same day.
The company's Annual General Meeting (AGM) is scheduled for Wednesday, 26 June 2024, at 2:00 pm CEST/1:00 pm BST. The virtual meeting will be open to all shareholders, with more details to be shared in due time.
Investors are invited to join the webinar via the Investor Meet Company platform, where they can engage in a presentation and Q&A session. Questions can be submitted before the event through the platform dashboard until 9:00 am the day before or during the live session itself. Automated French subtitles will be available.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news